KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Total Current Liabilities (2016 - 2025)

Amgen (AMGN) has 17 years of Total Current Liabilities data on record, last reported at $21.8 billion in Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 7.28% year-over-year to $21.8 billion; the TTM value through Sep 2025 reached $21.8 billion, up 7.28%, while the annual FY2024 figure was $23.1 billion, 25.59% up from the prior year.
  • Total Current Liabilities reached $21.8 billion in Q3 2025 per AMGN's latest filing, up from $20.5 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $23.1 billion in Q4 2024 and bottomed at $12.2 billion in Q4 2021.
  • Average Total Current Liabilities over 5 years is $17.2 billion, with a median of $17.0 billion recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: surged 49.12% in 2021, then fell 13.49% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $12.2 billion in 2021, then grew by 28.75% to $15.7 billion in 2022, then rose by 17.24% to $18.4 billion in 2023, then increased by 25.59% to $23.1 billion in 2024, then decreased by 5.66% to $21.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $21.8 billion in Q3 2025, $20.5 billion in Q2 2025, and $23.0 billion in Q1 2025.